HSCS (HeartSciences) Shares Outstanding (EOP): 3.18 Mil (As of Jan. 2026)


HSCS HeartSciences Inc HSCS
41 GF Score
Price $2.90
GF Value $2.61
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is HeartSciences Shares Outstanding (EOP)?

HeartSciences HSCS -1.18% 41 Shares Outstanding (EOP) is 3.18 Mil as of Jan. 2026. GuruFocus rates HSCS with a GF Score™ of 41/100 and a GF Value™ of $2.61 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. HeartSciences's shares outstanding for the quarter that ended in Jan. 2026 was 3.18 Mil.

HeartSciences's quarterly shares outstanding increased from Oct. 2025 (3.07 Mil) to Jan. 2026 (3.18 Mil). It means HeartSciences issued new shares from Oct. 2025 to Jan. 2026 .

HeartSciences's annual shares outstanding increased from Apr. 2024 (0.68 Mil) to Apr. 2025 (1.12 Mil). It means HeartSciences issued new shares from Apr. 2024 to Apr. 2025 .


HeartSciences  (NAS:HSCS) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


HeartSciences Shares Outstanding (EOP) Related Terms


HeartSciences Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for HeartSciences's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeartSciences Shares Outstanding (EOP) Chart

HeartSciences Annual Data
Trend Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Shares Outstanding (EOP)
Get a 7-Day Free Trial 0.08 0.08 0.10 0.68 1.12

HeartSciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.03 1.12 2.28 3.07 3.18

HSCS vs FEED, ITOC, LUDG: Shares Outstanding (EOP) Comparison

For the Medical Devices subindustry, HeartSciences's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeartSciences Shares Outstanding (EOP) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeartSciences's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where HeartSciences's Shares Outstanding (EOP) falls into.


HSCS
41GF Score
HeartSciences Inc HSCS
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeartSciences Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 3.18 Mil mean?
HeartSciences (HSCS) has a Shares Outstanding (EOP) of 3.18 Mil as of Jan. 2026. The total shares a company has outstanding, at period-end. View historical data on HeartSciences and its competitors.
Is HeartSciences' Shares Outstanding (EOP) too high?
HeartSciences' current Shares Outstanding (EOP) is 3.18 Mil. Overall, HeartSciences has a GF Score™ of 41/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HeartSciences' Shares Outstanding (EOP) compare to FEED and ITOC?
HeartSciences' Shares Outstanding (EOP) of 3.18 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Devices & Instruments company?
A good Shares Outstanding (EOP) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on HeartSciences and its competitors. HeartSciences's current Shares Outstanding (EOP) is 3.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartSciences stock overvalued right now?
Based on GuruFocus' analysis, HeartSciences (HSCS) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.61, compared to a current price of $2.90 — trading 11.1% above its estimated fair value. The current Shares Outstanding (EOP) is 3.18 Mil. HeartSciences' overall GF Score™ is 41/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For HeartSciences (HSCS), the current Shares Outstanding (EOP) is 3.18 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HeartSciences (HSCS) Overvalued in 2026?

Based on GuruFocus' analysis, HeartSciences stock appears to be overvalued. The current stock price of $2.90 is trading 11.1% above its estimated GF Value™ of $2.61. GuruFocus considers HeartSciences to be Modestly Overvalued.

Key valuation signals for HSCS:

  • Shares Outstanding (EOP): 3.18 Mil
  • GF Value™: $2.61 vs. price of $2.90 (11.1% above fair value)
  • GF Score™: 41/100 with 7 warning signs

No single metric tells the full story. See the HSCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HeartSciences Business Description

Address 550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
41GF Score

Get the complete analysis for HSCS

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.90
Price
$2.61
GF Value